Mitochondrial-Derived Peptide MOTS-c Suppresses Ovarian Cancer Progression by Attenuating USP7-Mediated LARS1 Deubiquitination.

This is a source-metadata record last found in a complete check on Sep 25, 2026. It is not a Pependium assessment of safety or effectiveness. Check the original sources for current details, corrections and full methods.

Source status: This saved record has not yet had a scheduled exact-ID status check. Check its original source links.

Study metadata

Study type: Original study
Study category (metadata hint): Other or unclear
Published: 2024-09-25
Authors: Yin Y, Li Y, Ma B, Ren C, Zhao S, Li J, Gong Y, Yang H
Journal or registry: Not reported
Registry study design: Not reported
Registry enrollment: Not reported
Funding agencies: Shaanxi Provincial Key Industry Innovation Chain; Shaanxi Provincial Natural Science Basic Research Program; Shaanxi Provincial Innovation Platform; National Natural Science Foundation of China
Identifiers: DOI: 10.1002/advs.202405620 · PMID: 39321430 · PMCID: PMC11578304
First found: Sep 25, 2026
Last found: Sep 25, 2026

Original sources

View at Europe PMC ↗